CDC: HIV Being Diagnosed Sooner After Infection

Share this content:
CDC: HIV Being Diagnosed Sooner After Infection
CDC: HIV Being Diagnosed Sooner After Infection

TUESDAY, Nov. 28, 2017 (HealthDay News) -- HIV is being diagnosed sooner after infection than previously reported, according to a Nov. 28 press release issued by the U.S. Centers for Disease Control and Prevention.

According to the release, there was a seven-month improvement over a four-year period, from a median of three years and seven months in 2011 to three years in 2015. In 2015, the estimated timing from HIV infection to diagnosis was a median of five years for heterosexual males, two-and-a-half years for heterosexual females and female injection drug users, and three years for gay and bisexual males. The estimated timing from infection to diagnosis also varied by race.

There was also an increase noted in the percentage of people at increased risk for HIV who reported getting an HIV test the previous year. However, an estimated 40 percent of new HIV infections originate in individuals who don't know they have HIV. In a recent study, 29, 42, and 59 percent, respectively, of gay and bisexual men, injection drug users, and heterosexuals at increased risk for HIV did not get an HIV test in the past year; 70 percent of high-risk individuals who were not tested in the past year visited a health care provider during that time period.

"HIV is being diagnosed more quickly, the number of people who have the virus under control is up, and annual infections are down," CDC Director Brenda Fitzgerald, M.D., said in a statement.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »